Your browser doesn't support javascript.
loading
The Specifically Androgen-Regulated Gene (SARG) Promotes Papillary Thyroid Carcinoma (PTC) Lymphatic Metastasis Through Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor 3 (VEGFR-3) Axis.
Xu, Shuai-Jun; Jin, Bin; Zhao, Wei-Jun; Chen, Xue-Xian; Tong, Ying-Ying; Ding, Xiao-Fei; Chen, Ying-Yuan; Wang, Dong-Hao; Wang, Zhi-Ming; Dai, Bing-Qing; Chen, Sai; Liang, Yong; Chen, Guang; Pan, Su-Jiao; Xu, Ling-Long.
Afiliación
  • Xu SJ; Department of Hematology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou University, Taizhou, China.
  • Jin B; Graduate School of Medicine, Hebei North University, Zhangjiakou, China.
  • Zhao WJ; Graduate School of Medicine, Hebei North University, Zhangjiakou, China.
  • Chen XX; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
  • Tong YY; Department of Hematology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou University, Taizhou, China.
  • Ding XF; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China.
  • Chen YY; Department of Hematology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou University, Taizhou, China.
  • Wang DH; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China.
  • Wang ZM; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
  • Dai BQ; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
  • Chen S; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
  • Liang Y; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
  • Chen G; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
  • Pan SJ; Department of Hematology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou University, Taizhou, China.
  • Xu LL; Department of Clinical Medicine , School of Medicine, Taizhou University, Taizhou, China.
Front Oncol ; 12: 817660, 2022.
Article en En | MEDLINE | ID: mdl-35769717

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China